Olink Holding AB (publ) - ADR
NASDAQ:OLK
| Market Cap (Intraday) | 1.81B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 184.38 |
| 10-Day MA | $14.87 |
| 50-Day MA | $16.15 |
| 200-Day MA | $20.01 |
Olink Holding AB (publ) - ADR Stock, NASDAQ:OLK
Uppsala Science Park, Uppsala, Uppsala 751 83
Sweden
Phone: +46.18.444.39.70
Number of Employees: 582
Description
Olink Holding AB provides accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. The firm offers a platform of products and services which are deployed across major biopharmaceutical companies and clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. It operates through the following segments: Kit and Service. The company was founded on December 13, 2018 and is headquartered in Uppsala, Sweden.